Over-the-counter medication · Vitamin B6 Supplement

pyridoxine

Also sold as Vitamin B6. PNV-DHA is used to help people who don't get enough vitamins and minerals from their diet.

Data updated 2026-05-15

2,439
FDA reportsLightly reported
1
InteractionFew interactions
3
Recall records

What the data shows

pyridoxine (Vitamin B6) is an over-the-counter Vitamin B6 Supplement, among the least-reported drugs the FDA tracks (2,439 FDA reports), with 1 documented drug interaction.

Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.

pyridoxine (Vitamin B6) is an over-the-counter Vitamin B6 Supplement. PNV-DHA is used to help people who don't get enough vitamins and minerals from their diet.

PNV-DHA is a multivitamin and mineral supplement. It helps manage nutritional deficiencies and provides extra nutrients.

Compare with Another Drug → Full Side Effects Report →

What it does

PNV-DHA is used to help people who don't get enough vitamins and minerals from their diet.

Common side effects

No common side effects listed.

Key warnings

Accidental overdose of iron-containing products can cause fatal poisoning in children under 6.

The sections below are summarized in plain English from pyridoxine's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.

How It Works

This medicine provides vitamins and minerals that your body needs. It helps to fill in any gaps in your diet. It ensures you get the right amount of nutrients.

Side Effects (from patient reports)

Based on 2,439 FDA adverse event reports.

Most-reported reactions

Adverse reactions in FAERS for pyridoxine, by number of reports

reports

What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.

Source FDA Adverse Event Reporting System (FAERS) As of 2025

Reports over time

Adverse-event reports filed for pyridoxine each year to the FDA Adverse Event Reporting System (FAERS).

0100200300400 20042007201020132016201920222025 283

Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.

Where pyridoxine sits

pyridoxine has more FDA adverse-event reports than 16% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.

fewest reports most reports

Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is pyridoxine; the line is the median (50th percentile).

FDA Adverse Event Report Analysis

Detailed analysis of 2,439 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2004–2025.

Total Reports

2,439

Reports Mentioning Death

501

20.5% of reports — not proof of cause

Hospitalization Reports

1,129

Top Indication

Product Used For Unknown Indication

Gender Distribution

Female 1,274 (57%)
Male 942 (42%)

Age Distribution

0–17 76
18–44 394
45–64 501
65–74 311
75+ 533

Most Reported Adverse Reactions (FAERS)

# Reaction Reports
2 NAUSEA 389
3 VOMITING 357
4 PAIN 306
5 GENERAL PHYSICAL HEALTH DETERIORATION 286
6 ABDOMINAL PAIN 276
7 ABDOMINAL DISTENSION 269
8 CONDITION AGGRAVATED 262
10 CONSTIPATION 255
11 HEADACHE 255
12 FATIGUE 253
13 SOMNOLENCE 253
14 SEPSIS 223
15 ASCITES 221
16 DIARRHOEA 220
17 HYPONATRAEMIA 216

Reactions in Death Reports

VOMITING 240
GENERAL PHYSICAL HEALTH DETERIORATION 239
ABDOMINAL DISTENSION 223
ABDOMINAL PAIN 216
ASCITES 212
APPENDICITIS 211
APPENDICOLITH 210
CONSTIPATION 207
NAUSEA 207
SEPSIS 206

Reactions in Hospitalization Reports

NAUSEA 216
VOMITING 215
SOMNOLENCE 200
CONDITION AGGRAVATED 196
GENERAL PHYSICAL HEALTH DETERIORATION 177
DRUG HYPERSENSITIVITY 169
FATIGUE 166
GASTROOESOPHAGEAL REFLUX DISEASE 166
SWELLING 165
ABDOMINAL PAIN 161

Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation

Serious Warnings

Accidental overdose of iron-containing products can cause fatal poisoning in children under 6. Keep this medicine out of the reach of children. If a child swallows too much, call a doctor or poison control center right away.

Known Drug Interactions

Decrease exposure Selective 5-HT3 Receptor Antagonists Ondansetron Decrease exposure Statins Metabolized by CYP3A4 Simvastatin Decrease exposure Thiazolidinediones Rosiglitazone Decrease AUC by 66% Tricyclic Antidepressants Nortriptyline A tuberculosis treatment regimen including rifampin (600 mg/day), isoniazid (300 mg/day), pyrazinamide (500 mg 3× per day), and pyridoxine (25 mg) was associated with higher than expected doses of nortriptyline were required to obtain a therapeutic drug level.

Mechanism: When these medications are taken together as part of a treatment plan, they can cause the body to process other drugs much faster, leading to lower levels in the blood.

This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.

Common Questions

What is PNV-DHA used for?
It is used to supplement your diet with vitamins and minerals.
How often should I take PNV-DHA?
Take one softgel daily.
Can I take this if I am allergic to any of the ingredients?
No, you should not take this if you are allergic to any of the ingredients.
What should I do if I miss a dose?
Take it as soon as you remember. If it is almost time for your next dose, skip the missed dose.
How should I store PNV-DHA?
Store it at room temperature.
Is PNV-DHA safe to take during pregnancy?
Yes, it can be taken before, during, and after pregnancy.
What do I do if a child swallows too much?
Call a doctor or poison control center immediately.
Does this medication have iron?
Yes, it contains iron.
What form does this medication come in?
It comes as a softgel.
Can I get an allergic reaction from this medicine?
Yes, allergic reactions have been reported with similar medications.
Does pyridoxine interact with other medications?
The registry has 1 documented interaction rows for pyridoxine. Notable source-record pairings include rifampin. These rows are not a complete medication review.
What drug class is pyridoxine?
pyridoxine belongs to the Vitamin B6 Supplement drug class. It is available over the counter (OTC). PNV-DHA is used to help people who don't get enough vitamins and minerals from their diet.
What pregnancy or breastfeeding source fields are listed for pyridoxine?
The FDA label for pyridoxine contains product-specific pregnancy or breastfeeding language. PlainMeds does not apply that source text to an individual.
Has pyridoxine been recalled?
There are 3 recalls associated with pyridoxine products. Lack of Assurance of Sterility. Check the recalls section below for full details and affected products.

Active Recalls

Class II November 17, 2016

Lack of Assurance of Sterility

Tri-Coast Pharmacy

Class II November 17, 2016

Lack of Assurance of Sterility

Tri-Coast Pharmacy

Class II November 17, 2016

Lack of Assurance of Sterility

Tri-Coast Pharmacy

Other drugs grouped near pyridoxine - same-class peers and common alternatives.

Compare pyridoxine vs ascorbic acid side-by-side →

Compare beyond drug class

Nationwide peers by FAERS volume & death-report share

Two PlainMeds-derived comparison paths for pyridoxine: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.

Medication Guides

What the FDA Data Shows for pyridoxine

The FDA label for pyridoxine (sold under brand names such as Vitamin B6) classifies it as an over-the-counter product in the Vitamin B6 Supplement class. PNV-DHA is used to help people who don't get enough vitamins and minerals from their diet. Labeling covers dosing, contraindications, and monitoring requirements derived from clinical trials.

Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 2,439 voluntary reports. The database also lists 1 documented drug interaction derived from FDA labeling, with the top-flagged interaction rated minor severity. Acquisition-cost data is surveyed weekly by CMS and updated as manufacturers report changes.

Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history (currently 3 recall records on file), and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.

Data Sources

Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS).

FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.

Last updated: January 15, 2024

PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.

Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.

All federal data sources used on this page